Cumberland Pharmaceuticals Inc (CPIX.OQ)
22 Jan 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|56||2016||Chairman of the Board, Principal Executive Officer|
|2016||Senior Director Finance and Accounting and Chief Financial Officer|
|70||2008||Senior Vice President, Chief Commercial Officer, Director|
|55||2012||Senior Vice President - Operations, Chief Development Officer|
|59||2011||Vice President - National Accounts, Chief Compliance Officer|
- BRIEF-Cumberland Pharmaceuticals Inc files for mixed shelf of up to $100 million
- BRIEF-Cumberland Pharmaceutical reports Q3 loss per share $0.05
- BRIEF-Cumberland Pharmaceuticals launches promotion of Totect in U.S. for emergency oncology intervention
- BRIEF-Cumberland Pharmaceuticals Q2 adjusted loss per share $0.05
- BRIEF-Cumberland Pharmaceuticals begin U.S. shipments of dexrazoxane for oncology patient support